SCHEMBL2929353

SCHEMBL2929353

CN1CCN(Cc2nc(Br)cs2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
MC4R P32245 1/20 0.40
LMNA P02545 2/20 0.38
STAT1 P42224 2/20 0.37
HTT P42858 2/20 0.37
MAPT P10636 4/20 0.37
ALDH1A1 P00352 3/20 0.37
GAA P10253 2/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
STAT3 P40763 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
CTSS P25774 1/20 0.36
CHKA P35790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12727034 0.84 HRH3 (0.44) KDM4ETDP1MAPTALDH1A1GAA
SCHEMBL17177230 0.83 HRH3 (0.46) KDM4ETDP1LMNAHTTALDH1A1
SCHEMBL553090 0.80 SMN1; SMN2 (0.50) KDM4ETDP1LMNAHTTMAPT
Hydrochloric Acid SCHEMBL907192 0.76 RAB9A (0.40) KDM4ETDP1MC4RLMNASTAT1
SCHEMBL2932554 0.76 KDM4E (0.39) KDM4ETDP1MC4RLMNASTAT1
SCHEMBL2928371 0.75 KDM4E (0.46) KDM4ETDP1MC4RLMNASMN1; SMN2
SCHEMBL14338850 0.70 ALOX15 (0.56) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A
SCHEMBL1168974 0.70 ALDH1A1 (0.53) KDM4ETDP1LMNAMAPTALDH1A1
SCHEMBL5256913 0.69 KDM4E (0.56) KDM4ETDP1MC4RLMNAMAPT
SCHEMBL2344269 0.68 CNR2 (0.60) KDM4ETDP1LMNASTAT1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260028365-A1 TYROSINE KINASE 2 INHIBITORS AND USES THEREOF BIOGEN MA INC (US) 2026-01-29 US disclosed
EP-2229377-A1 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS Wyeth LLC (US) 2010-09-22 EP disclosed
WO-2009076602-A1 5-ALKYL/ALKENYL-3-CYANOPYRIDINES AS KINASE INHIBITORS WYETH (US) 2009-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028365-A1 TYROSINE KINASE 2 INHIBITORS AND USES THEREOF TYK2, ERBB2, ROS1 KDM4E 1141/4885TDP1 933/4885MC4R 2748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.